# METHYLNALTREXONE BROMIDE
> **ANDA208592** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-05-28
## Drug
- **FDA Application Number:** ANDA208592
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHYLNALTREXONE BROMIDE
- **Generic name:** Methylnaltrexone Bromide
- **Active ingredients:** METHYLNALTREXONE BROMIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN LABS LTD
- **First approval:** 2025-05-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208592)
---
*AI Analytics · CC0 1.0*